Search Results 11-20 of 16480 for Strontium-89

  1. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. (PSMA-DC) - Mayo Clinic

    Short term ketoconazole treatment (< 28 days) is permitted. 3. Radiopharmaceutical agents (e.g., Strontium-89, PSMA-targeted radioligand therapy). 4 ...

  2. Radiopharmaceuticals Clinical Trials - Mayo Clinic Research

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  3. Medical Research & Education - Mayo Clinic News Network

    89 · 90 · 91 · 92 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  4. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    Wide field radiotherapy (including therapeutic radioisotopes such as strontium 89) ≤ 4 weeks or limited field radiation for palliation ≤ 2 weeks prior to ...

  5. Medical Research & Education - Mayo Clinic News Network

    89 · 90 · 91 · 92 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  6. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    Patients who have received wide field radiotherapy (including therapeutic radioisotopes such as strontium 89) ≤ 4 weeks or limited field radiation for ...

  7. Medical Research & Education - Mayo Clinic News Network

    89 · 90 · 91 · 92 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  8. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

    Systemic strontium-89, samarium-153, rhenium-186, or rhenium-188 for bone metastases within 24 weeks prior to initiation of study treatment; Spinal ...

  9. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  10. Technetium tc 99m oxidronate (injection route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...